Abstract. Traumatic injury to the adult spinal cord results in a massive loss of cells and permanent functional deficits. However, recent studies demonstrate that there is a proliferative response of endogenous glial precursors and progenitors and perhaps also pluripotent neural stem cells. These cells may prove to be an important new therapeutic target to improve recovery after injury to the spinal cord and brain.
Introduction
Spinal cord injury (SCI) causes loss of local segmental neurons, axons that pass through the site of injury, and local glial cells that are needed for the continued survival and normal function of remaining neuronal elements. In most mammalian species, even a relatively mild bruising of the spinal cord results in the formation of a central cavity that is devoid of neuronal elements. Permanent functional deficits are due to loss of local neuronal networks at the injury site as well as the interruption of axonal pathways carrying sensory information to the brain and of descending motor control pathways to the spinal cord distal to the injury site. Investigators have attempted to replace the lost tissue and reconstruct the injured spinal cord with a variety of tissue transplants and transplanted cells [62, 99, 116, 135] . The most recent experiments have utilized stem cells including pluripotent or pre-differentiated embryonic stem cells, embryonic or adult neural stem cells and bone marrow derived stem cells [42, 79, 90] . Other investigators have focused on the response of endogenous adult spinal cord stem and progenitor cells to SCI, as described below. Both avenues of investigation have demonstrated the difficulty of achieving substantial neurogenesis in the injured adult spinal cord.
On the other hand, significant improvement in recovery after SCI can occur when gliogenesis, specifically the generation of new oligodendrocytes, is increased after SCI through the transplantation of glial restricted stem cells or oligodendrocyte precursor cells (OPCs) [3, 23, 89] . Alternatively, it may be possible to stimulate endogenous adult OPCs to improve recovery after SCI.
This review will focus on the recent evidence that endogenous glial stem/progenitor/precursor cells are naturally stimulated to proliferate after traumatic spinal cord injury, recapitulate some aspect of normal development and contribute to the limited recovery of function that is seen. We will also consider the potential for enhancing this response and the possibility that cells with greater pluripotency, true neural stem cells, may be at least transiently activated by SCI.
Cell loss after SCI
The adult spinal cord is composed of a number of cell types. Some, for example the endothelial cells lining blood vessels, are similar (though not identical) to those found throughout the body. Some cell types are restricted to nervous tissue, such as neurons, and others are only found in the central nervous system (CNS). Classically, the latter include the ependymal cells that line the central canal of the spinal cord (and the ventricles of the brain) and supporting cells present throughout the tissue parenchyma that are termed neuroglia. These include astrocytes that function to regulate the ionic microenvironment surrounding the neurons and oligodendrocytes that myelinate axons in the CNS. In addition, as discussed further below, there are now believed to be significant numbers of non-neuronal cells in the adult CNS expressing the NG2 proteoglycan that may serve a variety of functions, including acting as glial progenitor cells.
The cells of the adult spinal cord not only interact metabolically and functionally but also via complex interdigitating cellular processes. Furthermore, the spinal cord is arranged with a central core of gray matter containing the local neuronal networks innervating each rostro-caudal segment of the body surrounded by white matter containing longitudinally arranged axons connecting these local networks to those above and below, as well as long tracts of axons conveying information to the brain and receiving directions from supraspinal centers. This anatomical organization means that a restricted injury to even one segment of the spinal cord results not only in local segmental loss of innervation but also causes loss of sensory perception and loss of motor function (paralysis) in all distal segments of the spinal cord.
In addition, an initial mechanical injury to the spinal cord initiates a series of "secondary injury" processes [8, 48] such that even a relatively mild bruise (contusion) of the spinal cord can results in massive cell loss and typically in the formation of a central cavity devoid of neurons or glial cells that persists chronically after SCI [88] .
Transplantation approaches to reconstruct the injured spinal cord
Given the massive cell loss at the injury site from even mild traumatic injury and the absence of spontaneous healing, there has been a long history of experimental transplantation of embryonic and/or adult nervous tissue used in attempts to "reconstruct" the injured spinal cord [62, 116, 135] . Key advances have been made with this approach. It has been convincingly demonstrated (1) that adult CNS neurons are capable of axonal regeneration when provided with a suitable environment, such as that provided by a peripheral nerve graft [14] , (2) that there are specific myelin-associated inhibitors of axonal regeneration [24] in the adult spinal cord (and brain) and that this inhibition can be experimentally reduced with specific strategies [16] and (3) that regenerative potential can be increased with exogenous neurotrophic factors [61, 94] , with combined strategies being the most effective [15, 78, 92] .
The recent explosion of knowledge about both embryonic stem cells and the presence of a neural stem cell pool in regions of the adult mammalian brain, has led to a number of studies in which embryonic or adult stem cells were transplanted into the injured spinal cord [42, 79, 90] . Initial results showed no functional benefits with the stem cells differentiating exclusively into astrocytes. More recently, stem cells that were partially pre-differentiated in tissue culture were used and oligodendrocytes, and in some cases even new neurons, appeared to be formed after transplantation into the injured spinal cord [63, 89] . Interestingly, when improved function has been observed after stem cell transplantation it appeared likely that it was due largely to improved myelination of original axons that survived SCI [54, 57] .
Endogenous stem/progenitor cells in the spinal cord
If stem cells, particularly glial stem/progenitor cells, are beneficial for recovery after SCI, are such cells already present in the adult spinal cord? Do they survive SCI? Do they proliferate in response to traumatic injury and play a role on the partial functional recovery often seen after SCI? To answer such question one needs to know the characteristics by which neural and glial stem/ progenitors cells in the injured adult spinal cord can be identified.
During embryonic development of the spinal cord, as in other parts of the CNS, pluripotent neural stem cell cells arise from cells of the primitive neural tube. As shown in Fig. 1 , these neural stem cells express specific transcription factors, including SOX1 and SOX2, as well as the intermediate filament protein, nestin [69] . Several recent papers argue that SOX2 is the best antigenic marker for these cells and is key to defining them as neural stem cells [33, 45, 93] . When SOX2 expression is down-regulated these cells enter either the neuronal or glial precursor cells lineage [45] . The former begin to express neuron-specific antigens and the latter then begin to express antigenic markers of the oligodendrocyte or astrocyte lineages. Figure 1 illustrates a current view of the developmental progression of stem cells, progenitors, and committed precursors in the formation of mature neurons and the glia in the in the spinal cord. The NG2+ cell is just one type of progenitor cell that arises from Sox2-expressing stem cells but it has been the most extensively studied, as summarized below. This schema is based on published studies by a number of investigators [1, [20] [21] [22] 25, 37, 69, 76, 106, 107, 118, 120, 122] . GRP = glial restricted precursor; MN/OLG = motor neuron/oligodendrocyte progenitor; OPC = oligodendrocyte progenitor cell.
NG2+ cells in the developing spinal cord
For immunohistochemical studies of tissue, the most useful marker of oligodendrocyte precursor cells (OPCs) during development is surface expression of the NG2 proteoglycan (for review, see [109] ). NG2 is a chondroitin sulfate proteoglycan that binds with high affinity to the growth factors basic fibroblast growth factor (bFGF) and platelet derived growth factor (PDGFαR) [44] , which are critical mitogens for oligodendrocyte precursor cells (OPCs) [4, 13] . It has been suggested that NG2 may potentiate growth factor effects by assembling them at the cell surface and presenting them to their respective receptors [109] . Furthermore, NG2 interacts with the cytoskeleton [66, 67] , which is necessary for NG2-mediated migration [35] . NG2 also acts as a mediator in transmembrane signaling, including activation of small GTPases [85] [86] [87] 101] , which interact with p21-activated kinases to initiate downstream signaling cascades involved in motility and alterations in morphology [73, 105] .
A great deal is already known about the proliferation and maturation of NG2 + oligodendrocyte progenitor cells in the developing spinal cord. During embryonic development, the neuroepithelial stem cell gives rise to multiple types of progenitor and precursor cells from restricted areas of the spinal cord. As depicted in Fig. 1 , the ventral pMN domain gives rise to a motor neuron/oligodendrocyteprecursor cell, from which 85-90% of mature oligodendrocytes arise [39] . A dorsal pool of glial restricted precursors (GRPs) from the dorsal domains dP3-dP5, gives rise to the remaining 10-15% of oligodendrocytes, although these OPCs arise two days after the ventral pool [22, 25, 37, 76, 120] . This pattern of oligodendrocyte development is similar to what occurs in the developing brain, specifically in the telencephalon [58] where ventral regions give rise to the first pool of OPCs which then migrate dorsally and dorsal regions then give rise to another wave of OPCs, which migrate ventrally.
In the rodent spinal cord, NG2 expression first occurs in OPCs at approximately embryonic day 12-13, and ultimately gives rise to mature, myelinating oligodendrocytes (For review, see [69] ). During spinal cord development, all cells that express the NG2 proteoglycan are regarded as embryonic OPCs [69, 82] , small undifferentiated cells that express PDGFαR [82] . In vitro, these cells also express A2B5 [1] , and go on to express the O4 and O1 antigens [107, 118] and galactocerebrocide (GalC, a mature oligodendrocyte marker), suggesting that NG2 + cells in the developing animal are OPCs [49] . In medium containing high serum content, these cells develop into type 2 astrocytes [97] . Therefore, NG2
+ cells are often referred to as O-2A, or oligodendrocyte-type 2 astrocyte progenitors. However, it is not known whether embryonic NG2+ cells give rise to astrocytes in vivo.
Transcription factor expression is correlated with maturation of NG2 + OPCs during embryonic development. As shown in Fig. 1 , many transcription factors are expressed at specific timepoints of lineage progression, and each has an important role in lineage specification and maturation. Dorsally and ventrally-derived OPC pools express specific transcription factors in the pre-OPC stage (Fig. 1) , but OPCs from both ventral and dorsal pools acquire Olig1, Olig2 and Nkx2.2 expression before progressing along the oligodendrocyte lineage [39, 59, 68, 95, 112, 125, 132, 133] . Knockout studies reveal that these transcription factors are necessary for lineage progression and/or (re)myelination , as summarized below.
While Olig1 is necessary for differentiation of early oligodendrocyte lineage cells, Olig2 is required for the formation of O4 + pre-myelinating oligodendrocytes during development, as shown in the cortices of Olig2 ablated mice [129] as well as in in vitro studies where antisense oligonucleotides are used to inhibit expression [39] . Olig2
−/− mice have no oligodendrocytes in the spinal cord [111] , with no effect in the hindbrain [131, 133] . Olig1/2 double knockouts result in elimination of motor neurons and a complete lack of mature oligodendrocytes [131, 133] .
In addition to Olig2, Nkx2.2 expression is necessary for OPCs to differentiate into mature, MBP-expressing oligodendrocytes [39, 95, 132] . Mutation of the Nkx2.2 gene causes a dramatic reduction in MBP and PLP expression [95] . Nkx2.2 −/− mice have no mature oligodendrocytes in the spinal cord [68] . Knocking out either Olig1/Olig2 or Nkx2.2 does not affect expression of Nkx2.2 or Olig1/Olig2, respectively.
During the early postnatal period, there is extensive proliferation of NG2+ cells in the spinal cord. As differentiation and myelination proceeds, the proliferation of NG2+ cells in the spinal cord tapers off. However, many NG2+ cells remain present in the normal adult spinal cord [52] .
NG2+ cells in the normal adult spinal cord
Bromodeoxyuridine (BrdU) incorporation studies have shown that mitotic NG2 + cells are the major population of dividing cells in the mature CNS [28, 51] , and have generally been referred to as AOPCs. Both OPCs and AOPCs can differentiate into mature oligodendrocytes and astrocytes in vitro [122] . However, AOPCs do not express CD-9, a protein expressed on the cell surface of OPCs involved in motility [115] . Additionally, studies done in the optic nerve reveal functional differences between AOPCs and their perinatal counterparts: 1) OPCs undergo quick, symmetrical division (∼ 18 hr), while AOPCs are slow and divide asymmet-rically (∼ 65 hr), 2) OPCs differentiate in less than 3 days, compared to a minimum of 5 days for AOPCs, and 3) OPCs migrate more quickly (21 µm/hr) than AOPCs (4 µm/hr) [122] . Similar rates have been reported in spinal cord NG2
+ cells [51] . It has been suggested that AOPCs are likely to be a mixed population containing multiple glial progenitor phenotypes, possibly including an astrocyte precursor cell population or a common glial progenitor [43, 81] .
Although spinal cord NG2+ cells during development are recognized as OPCs, the NG2 + cell population in the adult appears to be heterogenous, and is likely to be comprised of multiple cell types. NG2 + glia in the adult CNS have been collectively referred to as "polydendrocytes", which include, but are not restricted to, the adult OPC (AOPC) population [83] . The NG2
+ "synantocyte", a polydendrocyte subset,has been described as a morphologically complex, mature, specialized cell [10] . NG2
+ cells that express platelet derived growth factor receptor α (PDGFαR) have generally been considered AOPCs in the adult CNS [27, 100] . However, synantocytes express PDGFαR, making the distinction between the AOPC and synantocyte subpopulations of polydendrocytes difficult. The synantocytes described in vivo may be equivalent to the in vitro type-2 astrocyte that arises from NG2 + A2B5 + cells [10, 36, 40] . In vivo, however, synantocytes are functionally distinct from astrocytes; They do not express astrocyte markers such as the intermediate filaments glial fibrillary acidic protein (GFAP), vimentin, the calcium-binding protein S-100β, or glutamine synthetase (GS, involved in conversion of glutamate to glutamine) [19, 65, 83, 100] . The lack of intermediate filaments likely discounts synantocytes as functioning in physical support. Synantocytes and astrocytes both contact nodes of Ranvier and synapses [18, 119] , but astrocytes also form the glial limitans [18] , whereas synantocyte processes do not [18, 91] . Also, synantocytes are not dye-coupled through gap junctions [9] . Therefore, it is unlikely that synantocytes are an astrocytic population.
Proliferation of NG2+ cells after SCI

NG2
+ cells undergo division in response to different types of insult, including contusive SCI [50, 53, 56, 64, 72, 75, 98, 130] . A rat model of contusive SCI shows that NG2
+ cells proliferate after injury and that this proliferation is greatest 3 days after injury [130] . A BrdU pulse at this time-point results in many BrdUlabeled oligodendrocytes chronically, and oligodendrocyte density in the spared white matter is not different from uninjured controls at 6 weeks after injury in the rat [103] , suggesting that progenitor cells that divide in the acute injury phase have the ability to differentiate to repopulate the injured spinal cord to replace mature glia [50, 75, 130] . Furthermore, evidence for cell proliferation and replacement of mature oligodendrocytes and astrocytes has recently also been seen after SCI in a primate model [126] . NG2 + cell density in the injured spinal cord remains elevated for at many weeks after injury [75, 103, 130] . However, relatively little has been published on the identification of distinct sub-populations of NG2 + cells and their potential contributions in SCI. After transection of the anterior medullary velum, synantocytes, as identified by NG2 immunoreactivity and complex secondary and/or tertiary branching, undergo morphological transformation, proliferate, and migrate [21, 53, 64, 84, 91] . NG2
+ synantocytes contribute to the formation a protective glial scar in response to CNS injury [21] , a function generally attributed to astrocytes [32] . This response, however, has not been specifically observed in SCI. The role of synantocytes after SCI has not been elucidated.
The question remains as to whether NG2-expressing glia in the injured spinal cord are comprised of multiple populations with differential responses to injury; whether the NG2 pool contains OPCs, synantocytes, and/or other types of reactive or nascent cells, and what the developmental potential and lineage relations are among these cell types. The use of mouse injury models in which progenitor cells are genetically marked [26, 55] and/or can be followed by fate mapping techniques [63, 134] would be advantageous for studies of the endogenous stem/progenitor cell response to SCI.
However, some aspects of SCI in the mouse [6, 60, 104, 108] differ from that in rats, cats, and primates [7, 12, 88, 108, 113] . We therefore used a mouse version of our contusion injury model [60] to study cell loss, proliferation and replacement of glia after SCI in C57Bl/6 mice [72] . The results showed that, in addition to complete loss of gray and white matter in the lesion per se, the density of mature oligodendrocytes and astrocytes in spared white matter at the epicenter decreased significantly by 24 h after injury to about 50% of that in normal uninjured mice by 7 days after injury. NG2
+ cell density also initially decreased at 24 h, then increased so that by 7 dpi it was more than twice that in normal uninjured white matter. In order to further define the NG2 + cell population, we quantified NG2 + /Cd11b − cells (as some Cd11b+ macrophages/microglia transiently express NG2 after SCI), as well as NG2 + /nestin + cells. The results indicate that that most NG2 cells in the residual ventral white matter did not express Cd11b. Some 25-50% of NG2 + cells were also immunopositive for nestin, another progenitor cell marker, depending upon time after injury and distance from epicenter.
To determine whether the increased densities of some cell types was due to stimulation of cell proliferation occurring after injury we injected bromodeoxyuridine (BrdU), which labels proliferative cells in S-phase, during the 6 hours prior to perfusing the mice, at various times after injury . BrdU labeling was rarely observed in white matter of uninjured controls and very little in residual white matter at one day after SCI. However on days 3 and 7, many BrdU + nuclei were detected, including those of cells that expressed NG2 or Cd11b both in preserved white matter at the epicenter and in tissue at several mm distal to it. Maximal BrdU incorporation in NG2
+ cells occurred at 3 days after injury and in tissue rostral to the injury epicenter. When we performed double-labeling of cells that incorporated BrdU using antibodies against NG2 for progenitors and Cd11b for microglia/macrophages we found that NG2 + cells comprised 20-55% of BrdU-labled cells, depending upon location and time after injury with the peak at 3 days and at 1.5mm rostral to the injury epicenter. The peak of Cd11b + proliferation was observed at the injury epicenter at 7 days after injury.
The chronically injured C57BL6 mouse spinal cord was then examined for distribution of cells that incorporated BrdU on days 2-4 after injury and survived to 28 days. Double labeling was performed to determine if these cells became mature oligodendrocytes (CC1+), mature astrocytes (GFAP+), or remained NG2+ cells or microglia/macrophages (Cd11b+) We observed many CC1+ BrdU + oligodendrocytes and GFAP+ BrdU + astrocytes as well as NG2 + BrdU + cells in the spared white matter. In addition, there was a small proportion of Cd11b + cells and these cells were occasionally BrdU + . The observed glial cell loss and NG2 + cell response in the C57Bl/6 mouse is consistent with what has been reported in rats [2, 7, 8, 46, 75, 96, 103, 130] . Thus, mouse models, in which specific cell types are marked by the expression of a transgene such as enhanced green fluorescent protein (EGFP) may be used to further study the endogenous glial and precursor/progenitor cell response to SCI.
The difference we observed in the total numbers of NG2+ cells and of NG2+/nestin+ cells may reflect multiple types of NG2+ cells with differential responses to injury. It has been estimated that less than 1% of all NG2+ cells in the normal adult are truly AOPCs [115] and results from a recent study of NG2+ cells in tissue cultures from the injured rats spinal cord indicated that not all NG2+ cells can be accounted for by the oligodendrocyte lineage markers A2B5, O4, and O1 [71] . Furthermore, as discussed above, it has been postulated that the NG2+ population in the adult is heterogeneous and consists of several cell types [83] , including the synantocyte, which functions at nodes of Ranvier and at synapses [20] . These interactions could influence their proliferative response after injury [5, 31] . Taken together, our working hypothesis is that the injured spinal cord contains several types of glial cells that are capable of responding to injury, including NG2+ OPCs and NG2+ cells that are not in the oligodendrocyte lineage.
To test this hypothesis we are currently collaborating with Dr. Vittorio Gallo and using a transgenic mouse developed in his laboratory in which enhanced green fluorescent protein (EGFP) is expressed under the control of the 2'-3'-cyclic nucleotide 3'-phosphodiesterase (CNP) promoter [128] . This allows for visualization of the entire oligodendrocyte lineage, including progenitors. Results from our recent study with these CNP-EGFP mice [70] show that BrdU incorporation after SCI is stimulated both in CNP-EGFP+/NG2+ cells of the oligodendrocyte lineage as well as CNP-EGFP-/NG2+ cells that may belong to a second population of non-OPC NG2+ cells present in the adult spinal cord. We are examining specific transcription factors necessary for embryonic OPCs to become mature oligodendrocytes [68, 95, 131, 133] , and other proteins expressed by the NG2+ cells in the injured spinal cord to further distinguish the two populations. Interestingly, the temporal-spatial pattern of proliferation and transcription factor expression of the EGFP+ and EGFP-NG2+ cells seems to be distinct, suggesting they are different populations of precursor/progenitor cells stimulated by different environmental cues in the spinal cord after injury.
Evidence for the response of endogenous progenitor cells and neural stem cells in the injured adult spinal cord
The EGFP+ NG2+ cells stimulated by SCI in the CNP-EGFP mouse are presumably OPCs, that is, progenitor cells committed to the oligodendrocyte lineage.
The nature of the EGFP − NG2 + cells is currently unclear. They do not consistently express markers of astrocyte precursors [70] so they may be glial progenitor cells that can give rise to both astrocytes and synantocytes and possibly also to cells that enter the oligodendrocyte lineage, in which case they would begin to express CNP and thus EGFP. Chronically after SCI in both the rat and mouse [71, 103] the density of astrocytes and NG2+ cells in spared tissue is even higher than normal despite their significant initial loss after injury. Further, as stated above, BrdU-labeled astrocytes and NG2+ cells, as well as BrdU-labeled mature oligodendrocytes are observed chronically if animals are injected with BrdU during the first week after injury. Thus, the response to SCI of endogenous progenitor cell type(s) that can produce two or more mature glial cell types appears to be likely. This is consistent with what is observed during embryonic development when, as depicted in Fig. 1 , the Sox2+ Sox1+ nestin+ neuroepithelial stem cell gives rise to multipotent progenitors, specifically a glial-restricted progenitor dorsally and an oligodendrocyte/motor neuron progenitor ventrally. Further, results from BrdU-labeling studies demonstrate that the normal adult rodent spinal cord continues to contain a pool of progenitor cells [51] . Indeed, the progenitor cell yield of the lumbosacral spinal cord, as assayed by multipotency in culture, has been estimated to be similar to that from the lateral ventricle [121] . Taken together, the current evidence strongly suggests that there is a pool of normal glial progenitors in the adult spinal cord that appear to be stimulated by SCI.
The question remains, does SCI in the adult spinal cord stimulate endogenous pluripotent neural stem cells as well as the glial precursor/progenitor populations we have discussed. One established way to look for stem cell potential is to use "neurosphere" culture methods to determine whether putative progenitor cells are capable of self renewal and whether they are multipotent, that is, able to differentiate along multiple cell lineages. Cells cultured from the normal adult spinal cord can express neuronal markers when grown under the right experimental conditions, or when transplanted into neurogenic regions of the brain [38, 41, 114] . Thus, although the adult spinal cord is not a neurogenic region of the CNS, cells with neurogenic potential are present. Are such endogenous stem cells stimulated by SCI?
In addition to studies in vivo, we have recently used a clonal neurosphere culture approach to probe the potential of NG2+ cells from the injured spinal cord [127] .
We found not only are there more NG2+ cells in cell suspensions generated from the injured spinal cord but also that they produced more and larger "neurospheres". To test differentiation potential, the spheres were transferred to coated dishes to which they adhere and cultured with media that stimulated differentiation. We frequently saw oligodendrocytes differentiated from these clonally derived spheres. Less frequently they produced both oligodendrocytes and astrocytes, demonstrating at least some of the cells have bipotential glial progenitor potential. In addition, we have recently found that a least some spheres contain a high density of cells expressing both nestin and the SOX2 protein (Yoo and Wrathall, unplublished) , markers that characterize pluripotent embryonic neural stem cells. Further, SOX-2 immunoreactivity can also be detected in vivo in the injured spinal cord and appears to be up-regulated in ependymal cells of the central canal in the first week after SCI (Wrathall, unpublished) .
After SCI, in addition to proliferation of NG2+ cells in the spared tissue, several investigators have noted cell division in or near the central canal [7, 50, 80, 110] . This structure is similar anatomically to the embryonic neural tube from which neural stem cells are derived during development. It is also continuous with the ventricular system of the brain, portions of which continue to be neurogenic in the adult [34] . The ependymal cell proliferation seen after SCI has been associated with the formation of astrocytes [77] . However, one recent study based on performing spinal cord injury on nestinlacZ transgenic mice reports that NeuN positive cells are formed from dividing ependymal cells [55] , suggesting at least a transient attempt at neurogenesis. If ependymal cells that proliferate after SCI are SOX2+, it supports the concept that a there is also an endogenous neural stem cell response to SCI in addition to that of endogenous glial progenitors and OPCs.
Figure 2 summarizes our current view of the endogenous precursor, progenitor and stem cell response to SCI as deduced from studies on adult rats and mice after a contusion injury of the thoracic spinal cord.
Endogenous stem/progenitor cells and improving recovery after SCI
Although significant replacement of glial cells appears to occur naturally after SCI, many axons in the residual white matter are unmyelinated or abnormally myelinated chronically after experimental SCI [11, 117, 124] , suggesting that natural oligodendrocyte re- [70] , both OPCs and a non-OPC NG2+ cells are present throughout the parenchyma, and proliferate, especially in the ventrolateral white matter [72] . This cartoon is based on our own studies and those of other investigators [50, 72, 75, 80, 130] . placement may be quantitatively and/or qualitatively suboptimal. Indeed, we have reported that an acute treatment that has no effect on acute axonal loss but spares oligodendrocytes, significantly enhances hind limb function after a standardized thoracic SCI [102, 123] . Furthermore, demyelination and abnormal remyelination, have also been observed chronically and linked to functional deficits in humans after SCI [17, 29, 30, 47, 74] . Similarly, the persistent "reactive" phenotype of astrocytes chronically after SCI, suggests that although their numbers may be normalized (or greater than normal), their functioning is not. If the response of endogenous stem/precursor cells to SCI could be enhanced to result in the replacement of more glia and/or glia that functioned more normally, recovery after incomplete SCI would likely be improved. Enough is known about growth factors that stimulate the proliferation and differentiation of glial progenitors to experiment with whether this approach has therapeutic potential for spinal cord injury.
The replacement of lost neurons is more problematic as the appropriate function of many require growth of long axonal processes to distant targets and, as discussed earlier, the adult spinal cord contain inhibitors of such axonal growth. However, small interneurons that act locally in segmental networks are lost in SCI as well as the large neurons with long axons. The former are the sort of neurons that are replaced in the neurogenic regions of the adult brain -small local inhibitory interneurons. Perhaps, if we could induce endogenous neural stem cells to proliferate and differentiate into such interneurons, they could contribute to improved functional recovery after SCI.
Conclusions
Spinal cord injury is devastating because so many cells and their widespread connections are lost even after a mild traumatic injury, and the natural replacement of these cells and their essential connections is insufficient. Nevertheless, there is recent evidence in clinically relevant rodent models of SCI that there is extensive proliferation of glial precursor and progenitor cells and perhaps proliferation of neural stem cells. In the future, as we learn how to manipulate adult stem and progenitor cells, it may be possible to therapeutically enhance the response of the endogenous cells to increase functional recovery after injury.
